Related Experiment Videos
Albumin utilization in a university hospital
M R Alexander1, J L Stumpf, T T Nostrant
1Department of Pharmacy Services, Detroit Receiving Hospital, MI.
DICP : the Annals of Pharmacotherapy
|March 1, 1989
Summary
High-priced medical agents like human serum albumin are often used inappropriately, increasing healthcare costs. A review found 74% of human serum albumin use was inappropriate, costing an estimated $281,000 annually.
Area of Science:
- Pharmacoeconomics
- Healthcare Management
- Clinical Pharmacy
Background:
- High-cost medications, such as human serum albumin, contribute significantly to escalating healthcare expenditures.
- Optimizing the utilization of expensive medical agents is crucial for cost containment in healthcare settings.
Purpose of the Study:
- To assess the appropriateness of human serum albumin (HSA) utilization at a major hospital.
- To quantify the financial impact of potentially inappropriate HSA prescribing.
Main Methods:
- A retrospective utilization review was performed.
- Prescribing data for 81 patients receiving 935 units of HSA were evaluated against established criteria.
- Inappropriate use was identified and its associated costs were projected.
Main Results:
- A significant majority of HSA units, 692 out of 935 (74%), were deemed inappropriate for use.
- The projected annual financial impact of this inappropriate utilization exceeded $281,000.
- This highlights a substantial area for potential cost savings.
Conclusions:
- Inappropriate prescribing of human serum albumin represents a considerable financial burden.
- Targeted interventions and utilization reviews are essential for optimizing the use of high-cost medications.
- Implementing evidence-based prescribing guidelines can improve resource allocation in hospitals.